self.document.write(decodeURIComponent('%3Cdiv%20style%3D%22font-family%3A%20Tahoma%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%20font-size%3A%209pt%3B%20text-decoration%3A%20none%3B%20margin%3A%200px%3B%20padding%3A%200.5em%201em%3B%20background-color%3A%20%23E6E6E6%3B%22%3E%3Cdiv%3E%3Ca%20href%3D%22http%3A%2F%2Fwww.newsfeedmaker.com%2Farticle%2F14274378c466%2F64ccd98a%22%20style%3D%22font-size%3A%2011px%3B%20color%3A%20%23191919%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3EAthersys%20Announces%20Positive%20Results%20from%20Phase%20I%20Study%20of%20Multistem%28R%29%20in%20%3Cstrong%20class%3D%22searchterm%22%3EHeart%20Attack%3C%2Fstrong%3E%20Patients%3C%2Fa%3E%20%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23808080%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E28%20Jul%202010%2020%3A30%2C%20%3C%2Fspan%3E%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3ENews%20Blaze%3C%2Fspan%3E%3Cp%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E...%20Athersys%20Announces%20Positive%20Results%20from%20Phase%20I%20Study%20of%20Multistem%28R%29%20in%20%3Cstrong%20class%3D%22searchterm%22%3EHeart%20Attack%3C%2Fstrong%3E%20Patients%20Stem%20Cell%20Therapy%20Well%20Tolerated%20at%20All%20Dose%20Levels%20CLEVELAND%2C%20July%2028%2C%202010%20%20...%3C%2Fp%3E%3C%2Fdiv%3E%3Cdiv%3E%3Ca%20href%3D%22http%3A%2F%2Fwww.newsfeedmaker.com%2Farticle%2F15277374ce90%2F64ccd98a%22%20style%3D%22font-size%3A%2011px%3B%20color%3A%20%23191919%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3EAngiotech%20Pharmaceuticals%20and%20partner%20Athersys%20announce%20positive%20results%20from%20phase%20I%20study%20of%20MultiStem%28R%29%20in%20%3Cstrong%20class%3D%22searchterm%22%3Eheart%20attack%3C%2Fstrong%3E%20patients%3C%2Fa%3E%20%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23808080%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E28%20Jul%202010%2020%3A51%2C%20%3C%2Fspan%3E%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3EPR%20Newswire%3C%2Fspan%3E%3Cp%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E...%20%20Pharmaceuticals%20and%20partner%20Athersys%20announce%20positive%20results%20from%20phase%20I%20study%20of%20MultiStem%28R%29%20in%20%3Cstrong%20class%3D%22searchterm%22%3Eheart%20attack%3C%2Fstrong%3E%20patients%20%2FPRNewswire-FirstCall%2F%20-%20Angiotech%20Pharmaceuticals%2C%20Inc.%20%28NASDAQ%3A%20ANPI%2C%20TSX%3A%20ANP%29%20%28%26quot%3BAngiotech%26quot%3B%29%20and%20partner%20Athersys%2C%20%20...%3C%2Fp%3E%3C%2Fdiv%3E%3Cdiv%3E%3Ca%20href%3D%22http%3A%2F%2Fwww.newsfeedmaker.com%2Farticle%2F15274375c0fa%2F64ccd98a%22%20style%3D%22font-size%3A%2011px%3B%20color%3A%20%23191919%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3EAngiotech%20Pharmaceuticals%20and%20partner%20Athersys%20announce%20positive%20results%20from%20phase%20I%20study%20of%20MultiStem%28R%29%20in%20%3Cstrong%20class%3D%22searchterm%22%3Eheart%20attack%3C%2Fstrong%3E%20patients%20%28CNW%29%3C%2Fa%3E%20%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23808080%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E28%20Jul%202010%2020%3A50%2C%20%3C%2Fspan%3E%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3EAlphaTrade%20Finance%3C%2Fspan%3E%3Cp%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E...%20%20is%20well%20tolerated%20when%20administered%20to%20the%20damaged%20region%20of%20the%20heart%20following%20a%20%3Cstrong%20class%3D%22searchterm%22%3Eheart%20attack%3C%2Fstrong%3E%2C%26quot%3B%20said%20Dr.%20Penn.%20%26quot%3BMultiStem%27s%20safety%20profile%2C%20together%20with%20trends%20suggesting%20meaningful%20improvement%20in%20functional%20%20...%3C%2Fp%3E%3C%2Fdiv%3E%3Cdiv%3E%3Ca%20href%3D%22http%3A%2F%2Fwww.newsfeedmaker.com%2Farticle%2F11270373b5a9%2F64ccd98a%22%20style%3D%22font-size%3A%2011px%3B%20color%3A%20%23191919%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3ETrophos%20publishes%20the%20identification%20and%20characterization%20of%20the%20novel%20cardioprotective%20compound%2C%20TRO40303%3C%2Fa%3E%20%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23808080%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E28%20Jul%202010%2012%3A31%2C%20%3C%2Fspan%3E%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3EPharmalive.com%2F%3C%2Fspan%3E%3Cp%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E...%20%20from%20ischemia-reperfusion%20injury%20induced%20when%20treating%20myocardial%20infarction%20%28MI%2C%20commonly%20referred%20to%20as%20a%20heart%20attack%29.%20TRO40303%20is%20the%20second%20most%20advanced%20cholesterol%20oxime%20to%20be%20discovered%20by%20Trophos%20and%20%20...%3C%2Fp%3E%3C%2Fdiv%3E%3Cdiv%3E%3Ca%20href%3D%22http%3A%2F%2Fwww.newsfeedmaker.com%2Farticle%2F1a27e3710872%2F64ccd98a%22%20style%3D%22font-size%3A%2011px%3B%20color%3A%20%23191919%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3ESenior%20citizens%20get%20free%20screening%20and%20health%20advice%3C%2Fa%3E%20%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23808080%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E23%20Jul%202010%2022%3A50%2C%20%3C%2Fspan%3E%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3EThe%20Star%20Online%3C%2Fspan%3E%3Cp%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E...%20%20screenings%20were%20also%20given%20free%20health%20advice%20and%20tips%20for%20common%20health%20problems%20like%20%3Cstrong%20class%3D%22searchterm%22%3Eheart%20attack%2C%3C%2Fstrong%3E%20stroke%2C%20high%20blood%20pressure%20and%20diabetes.%20MBSA%20welcomes%20further%20collaborations%20with%20corporations%2C%20NGOs%20and%20%20...%3C%2Fp%3E%3C%2Fdiv%3E%3Cdiv%3E%3Ca%20href%3D%22http%3A%2F%2Fwww.newsfeedmaker.com%2Farticle%2F1a27e3720877%2F64ccd98a%22%20style%3D%22font-size%3A%2011px%3B%20color%3A%20%23191919%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3EHealth%20screening%20programme%20in%20Shah%20Alam%3C%2Fa%3E%20%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23808080%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E23%20Jul%202010%2022%3A50%2C%20%3C%2Fspan%3E%3Cspan%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3EThe%20Star%20Online%3C%2Fspan%3E%3Cp%20style%3D%22font-size%3A%2010px%3B%20color%3A%20%23404040%3B%20font-weight%3A%20normal%3B%20font-style%3A%20normal%3B%22%3E...%20%20will%20also%20be%20given%20free%20health%20advice%20and%20tips%20for%20common%20health%20problems%20like%20%3Cstrong%20class%3D%22searchterm%22%3Eheart%20attack%2C%3C%2Fstrong%3E%20stroke%2C%20high%20blood%20pressure%20and%20diabetes.%20In%20addition%2C%20the%20programme%20features%20health%20quizzes%2C%20exhibitions%20%20...%3C%2Fp%3E%3C%2Fdiv%3E%3Cp%3E%3Ca%20style%3D%22font-size%3A%2011px%3B%20color%3A%20%23191919%3B%22%20href%3D%22http%3A%2F%2Fwww.newsfeedmaker.com%2Ffeed-archive%2F64ccd98a%22%3EMore%20News%20%26raquo%3B%3C%2Fa%3E%3C%2Fp%3E%3C%2Fdiv%3E'));